BHVN logo

Biohaven (BHVN) EBITDA

annual EBITDA:

-$877.26M-$448.12M(-104.42%)
December 31, 2024

Summary

  • As of today (May 29, 2025), BHVN annual EBITDA is -$877.26 million, with the most recent change of -$448.12 million (-104.42%) on December 31, 2024.
  • During the last 3 years, BHVN annual EBITDA has fallen by -$659.75 million (-303.32%).
  • BHVN annual EBITDA is now -8615.04% below its all-time high of -$10.07 million, reached on December 31, 2015.

Performance

BHVN EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBHVNincome statement metrics

quarterly EBITDA:

-$219.31M-$31.84M(-16.99%)
March 31, 2025

Summary

  • As of today (May 29, 2025), BHVN quarterly EBITDA is -$219.31 million, with the most recent change of -$31.84 million (-16.99%) on March 31, 2025.
  • Over the past year, BHVN quarterly EBITDA has dropped by -$37.52 million (-20.64%).
  • BHVN quarterly EBITDA is now -7247.24% below its all-time high of -$2.98 million, reached on March 1, 2016.

Performance

BHVN quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBHVNincome statement metrics

TTM EBITDA:

-$914.78M-$37.52M(-4.28%)
March 31, 2025

Summary

  • As of today (May 29, 2025), BHVN TTM EBITDA is -$914.78 million, with the most recent change of -$37.52 million (-4.28%) on March 31, 2025.
  • Over the past year, BHVN TTM EBITDA has dropped by -$379.98 million (-71.05%).
  • BHVN TTM EBITDA is now -30545.80% below its all-time high of -$2.98 million, reached on March 1, 2016.

Performance

BHVN TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBHVNincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

BHVN EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-104.4%-20.6%-71.0%
3 y3 years-303.3%-145.0%-369.1%
5 y5 years-79.6%-38.8%-54.7%

BHVN EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-303.3%at low-226.1%+33.9%-369.1%at low
5 y5-year-666.6%at low-336.9%+33.9%-767.4%at low
alltimeall time-8615.0%at low-7247.2%+33.9%<-9999.0%at low

BHVN EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
-$219.31M(+17.0%)
-$914.78M(+4.3%)
Dec 2024
-$877.26M(+104.4%)
-$187.47M(+6.4%)
-$877.26M(+4.2%)
Sep 2024
-
-$176.17M(-46.9%)
-$841.60M(+8.7%)
Jun 2024
-
-$331.82M(+82.5%)
-$774.44M(+44.8%)
Mar 2024
-
-$181.79M(+19.7%)
-$534.80M(+24.6%)
Dec 2023
-$429.14M(-24.3%)
-$151.82M(+39.3%)
-$429.14M(-12.5%)
Sep 2023
-
-$109.01M(+18.3%)
-$490.39M(+9.3%)
Jun 2023
-
-$92.18M(+21.1%)
-$448.64M(-18.9%)
Mar 2023
-
-$76.13M(-64.3%)
-$553.16M(-2.4%)
Dec 2022
-$566.55M(+160.5%)
-$213.07M(+216.8%)
-$566.55M(+40.3%)
Sep 2022
-
-$67.26M(-65.8%)
-$403.68M(+3.1%)
Jun 2022
-
-$196.69M(+119.7%)
-$391.68M(+100.9%)
Mar 2022
-
-$89.52M(+78.3%)
-$194.99M(+84.9%)
Dec 2021
-$217.51M(+90.1%)
-
-
Dec 2021
-
-$50.20M(-9.2%)
-$105.46M(-55.1%)
Sep 2021
-
-$55.27M(-69.2%)
-$234.83M(-64.6%)
Dec 2020
-$114.43M(-76.6%)
-
-
Dec 2020
-
-$179.56M(+8.4%)
-$663.44M(+6.8%)
Sep 2020
-
-$165.69M(+3.4%)
-$621.34M(+13.0%)
Jun 2020
-
-$160.22M(+1.4%)
-$549.80M(-7.0%)
Mar 2020
-
-$157.97M
-$591.47M
DateAnnualQuarterlyTTM
Dec 2019
-$488.45M(+113.8%)
-
-
Dec 2019
-
-$137.45M(+46.0%)
-$488.89M(+22.1%)
Sep 2019
-
-$94.15M(-53.4%)
-$400.40M(+10.6%)
Jun 2019
-
-$201.90M(+264.6%)
-$361.89M(+82.1%)
Mar 2019
-
-$55.38M(+13.1%)
-$198.73M(-13.1%)
Dec 2018
-$228.46M(+81.1%)
-
-
Dec 2018
-
-$48.96M(-12.0%)
-$228.73M(+10.3%)
Sep 2018
-
-$55.65M(+43.6%)
-$207.39M(+6.7%)
Jun 2018
-
-$38.74M(-54.6%)
-$194.37M(+0.6%)
Mar 2018
-
-$85.38M(+209.0%)
-$193.30M(+53.2%)
Dec 2017
-$126.18M(+100.1%)
-
-
Dec 2017
-
-$27.63M(-35.2%)
-$126.18M(+2.1%)
Sep 2017
-
-$42.62M(+13.1%)
-$123.64M(+13.2%)
Jun 2017
-
-$37.68M(+106.4%)
-$109.18M(+39.4%)
Mar 2017
-
-$18.25M(-27.2%)
-$78.32M(+24.2%)
Dec 2016
-$63.06M(+526.5%)
-
-
Dec 2016
-
-$25.09M(-10.9%)
-$63.06M(+66.1%)
Sep 2016
-
-$28.17M(+313.1%)
-$37.97M(+287.3%)
Jun 2016
-
-$6.82M(+128.4%)
-$9.80M(+228.4%)
Mar 2016
-
-$2.98M
-$2.98M
Dec 2015
-$10.07M
-
-

FAQ

  • What is Biohaven annual EBITDA?
  • What is the all time high annual EBITDA for Biohaven?
  • What is Biohaven annual EBITDA year-on-year change?
  • What is Biohaven quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Biohaven?
  • What is Biohaven quarterly EBITDA year-on-year change?
  • What is Biohaven TTM EBITDA?
  • What is the all time high TTM EBITDA for Biohaven?
  • What is Biohaven TTM EBITDA year-on-year change?

What is Biohaven annual EBITDA?

The current annual EBITDA of BHVN is -$877.26M

What is the all time high annual EBITDA for Biohaven?

Biohaven all-time high annual EBITDA is -$10.07M

What is Biohaven annual EBITDA year-on-year change?

Over the past year, BHVN annual EBITDA has changed by -$448.12M (-104.42%)

What is Biohaven quarterly EBITDA?

The current quarterly EBITDA of BHVN is -$219.31M

What is the all time high quarterly EBITDA for Biohaven?

Biohaven all-time high quarterly EBITDA is -$2.98M

What is Biohaven quarterly EBITDA year-on-year change?

Over the past year, BHVN quarterly EBITDA has changed by -$37.52M (-20.64%)

What is Biohaven TTM EBITDA?

The current TTM EBITDA of BHVN is -$914.78M

What is the all time high TTM EBITDA for Biohaven?

Biohaven all-time high TTM EBITDA is -$2.98M

What is Biohaven TTM EBITDA year-on-year change?

Over the past year, BHVN TTM EBITDA has changed by -$379.98M (-71.05%)
On this page